Prodrugs of succinic acid for increasing atp production

MA39856AUndetermined Publication Date: 2017-02-15NEUROVIVE PHARMA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA39856
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-04-08
Filing Date
2015-04-08
Publication Date
2017-02-15
Patent Text Reader

Abstract

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing atp-production in mitochondria. The main part of atp produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the kreb's cycle. Not all kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial atp-output.
Need to check novelty before this filing date? Find Prior Art